Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dalton Alencar Fischer Chamone
BCL-2 Protein Frequency in Patients With High-Risk Diffuse Large B-Cell Lymphoma
Sao Paulo Medical Journal
Medicine
Related publications
Combination of BCL-2 and MYC Protein Expression Improves High-Risk Stratification in Diffuse Large B-Cell Lymphoma
OncoTargets and Therapy
Oncology
Pharmacology
Plasma Immunoprofiling of Patients With High-Risk Diffuse Large B-Cell Lymphoma: A Nordic Lymphoma Group Study
Blood Cancer Journal
Oncology
Hematology
High-Risk Patients With Diffuse Large B-Cell Lymphoma Are Not Enrolled on Clinical Trials
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Young High Risk Patients With Diffuse Large B-Cell Lymphoma Including BCL-2/Myc Double Hit Lymphomas Benefit From Dose-Dense Immunochemotherapy With Early CNS Prophylaxis
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Frequent Expression of CD10 and BCL-6 in High-Grade Primary Extranodal Lymphoma With Diffuse Large B-Cell Lymphoma Morphology
Journal of clinical and experimental hematopathology : JCEH
Medicine
Diffuse Large B-Cell Lymphoma
Prognostic Value of Baseline FDG Pet Parameters in High Risk Diffuse Large B-Cell Lymphoma Patients
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A New Subtype-Specific Monoclonal Antibody for IAP-survivin Identifies High-Risk Patients With Diffuse Large B-Cell Lymphoma and Improves the Prognostic Value of BCL-2
International Journal of Oncology
Cancer Research
Oncology
Blood Lymphocyte-To-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated With R-Chop
PLoS ONE
Multidisciplinary
